Tracheostomy

Pahor AL . Ear, nose and throat in Ancient Egypt: Part II. J Laryng 1992;106:773–9.

Pack GT Campbell R . Historical case records of cancer: The laryngeal cancer of Frederick III in Germany. Ann Med Hist 1940;2:151–70.

Chalet NI . Sir Morell MacKenzie revisited. Laryngoscope 1984;94:1307–10.

Minnigerode B . The disease of Emperor Frederick III. Laryngoscope 1986;96:200–3.

Pahor AL . What killed Kaiser Frederick III? XXXIIIrd International Congress on The History of Medicine, Granada, September, 1992 (in press).

MacKenzie Morell Sir . The Fatal Illness of Frederick the Noble. London: Sampson Low, Marston, Searle and Rivington, 1888.

Pahor AL . What killed Kaiser Frederick III. First Meeting of the British Section of European Society for the History of Otorhinolaryngology, Birmingham, 1981.

Freeman AG . Cyanocobalamin — a case for withdrawal: Discussion paper. J Roy Soc Med 1992;85:686–7.

Lederle FA . Oral cobalamin for pernicious anemia: Medicine's best kept secret? JAMA 1991;265:94–5.

Berlin H Berlin R Brante G . Oral treatment of pernicious anemia with high doses of vitamin B₁₂ without intrinsic factor. Acta Med Scand 1968;184:247–58.

Matthews DM . Distribution of cobalamins in the animal body. In: Zagalak B Friedrich W , eds. Vitamin B12: Proceedings of the 3rd European Symposium. Berlin: De Gruyter, 1979:681–94.

Drugs and therap Bull 1984;22:43–4.

Chipping PM . Vitamin V12 deficiency. Preservers' J 1988;28:117–24.

British National Formulary. March 1991:296–7.

Freeman AG . Chronic cyanide intoxication. BMJ 1981;282:1321.

Frost EAM . In: Eger E I II (ed). Central nervous effects of nitrous oxide in nitrous oxide/N₂O. New York: Elsevier, 1985:157–76.

Gillman MA Lichtigfeld FJ . Analgesic nitrous oxide in neuropsychiatry: Past present and future. Int J Neurosci 1989;49:75–81.

Nunn JF Chanarin I . In: Eger E I II (ed). Nitrous oxide inactivates methionine synthetase in nitrous oxide/N₂O. New York: Elsevier, 1985:211–33.

Gillman MA . Haematological changes caused by nitrous oxide, cause for concern? Editorial. Br J Anaesth 1987;59:143–5.

Gillman MA Lichtigfeld FJ . Analgesic nitrous oxide for alcohol withdrawal: A critical appraisal after 10 years' use. Postgrad Med J 1990;66:543–6.

Harper SJ Wilkes RG . Posthypoxic myoclonus (the Lance-Adams syndrome) in the intensive care unit. Anaesthesia 1991;46:199–201.

Obeso JA Artieda J Rothwell JC Day B Thompson P Marsden CD . The treatment of severe action myoclonus. Brain 1989;112:765–77.

Jenner P Pratt JA Marsden CD . Mechanism of action of clonazepam in myoclonus in relation to effects of GABA and 5-HT. Adv Neurol 1986;43:629–43.

Coletti A Mandelli A Minoli G Tredici G . Post-anoxic action myoclonus (Lance-Adams syndrome) treated with levodopa and GABAergic drugs. J Neurol 1980;223:67–70.

Fahn S . Posthypoxic action myoclonus: Literature review update. Adv Neurol 1985;43:157–69.

Tacconi MT Wurtman RJ . Piracetam: Physiological disposition and mechanism of action. Adv Neurol 1986;43:675–85.

Terwinghe G Daumerie J Nicaise C Rosillon O . Effet therapeutique du piracetam dans un cas de myoclonie d'action postanoxique. Acta Neurol Belg 1978;78:30–6.

Cremieux C Serratrice G . Myoclonie d'intention et d'action post-anoxique: Amélioration par le piracetam. Nouv Presse Med 1979;41:3357–8.

Fahn S . Newer drugs for posthypoxic action myoclonus: Observations from a well-studied case. Adv Neurol 1986;43:197–9.